• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of health communication >How direct-to-consumer drug websites convey disease information: Analysis of stigma-reducing components
【24h】

How direct-to-consumer drug websites convey disease information: Analysis of stigma-reducing components

机译：直接面向消费者的药品网站如何传达疾病信息：减少耻辱感的成分的分析

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Given the growing trend of the Internet as a source of health information, this study evaluated whether direct-to-consumer prescription drug websites for stigmatized illnesses contained stigma-reducing components: onset controllability, offset controllability, and recategorization. The authors examined the contents of the first-level homepages and the second-level pages in 88 stand-alone websites for 15 different stigmatized conditions. Overall, about a third of the websites did not provide a direct link to detailed disease information on the homepage. On the homepages, three stigma-reducing components were rarely offered either through textual or visual cues. On the second level, in terms of textual cues, onset controllability and recategorization were the most prevalent, while offset controllability was relatively less frequent. There were no visual cues on the second level. Results point out the limited and insufficient stigma-reducing components of direct-to-consumer prescription drug websites.
机译：考虑到作为健康信息来源的互联网的增长趋势，本研究评估了针对受歧视的疾病的直接面向消费者的处方药网站是否包含减少耻辱感的成分：发病可控性，抵消可控性和重新分类。作者检查了88个独立网站中第一级首页和第二级页面的内容，以了解15种不同的带有污名化的情况。总体而言，大约三分之一的网站未提供直接链接至首页上详细的疾病信息。在主页上，很少通过文字或视觉提示提供减少污名的三个组件。在第二级上，就文本提示而言，开始可控性和重新分类最为普遍，而偏移可控性相对较少。第二层没有视觉提示。结果指出，直接面向消费者的处方药网站减少污名的成分有限且不足。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号